|
| Read more ›› |
|
By: PR Newswire Association LLC. - 07 Apr 2021
|
|
Related companies:
InDex Pharmaceuticals Holding AB |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 07 Apr 2021
|
|
Related companies:
BioInvent International AB |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 07 Apr 2021
|
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 07 Apr 2021
|
|
Related companies:
Essity Aktiebolag |
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Apr 2021
|
|
Related companies:
PCI Biotech Holding ASA |
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Apr 2021
|
|
Related companies:
Evaxion Biotech A/S |
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Apr 2021
|
|
Related companies:
Novozymes A/S |
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Apr 2021
|
|
Related companies:
BioPorto Diagnostics A/S |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 06 Apr 2021
|
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 06 Apr 2021
|
|
Related companies:
Medivir AB |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 06 Apr 2021
|
|
Related companies:
UNION therapeutics A/S |
|
|
| Simple, Non-Invasive Blood Test Poses No Risk to Pregnant Woman and Fetus; Significantly Safer, More Comprehensive and More Inclusive Compared to Invasive Tissue Sampling Test;Intended for All Pregnant Women, Not Just High-Risk Categories, at 10-14 Weeks of Pregnancy; Earlier Administration Potentially... Read more ›› |
|
By: PR Newswire Association LLC. - 06 Apr 2021
|
|
Related companies:
ARCEDI Biotech ApS |
|
|
| - New shorter duration of dual anti-platelet therapy (DAPT) post XIENCE stent implant provides physicians with additional options to treat patients at high risk of bleeding;- XIENCE is the most used drug eluting stent in the world, and European approval for shorter DAPT is supported by two studies... Read more ›› |
|
By: PR Newswire Association LLC. - 06 Apr 2021
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Apr 2021
|
|
Related companies:
Genmab A/S |
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Apr 2021
|
|
Related companies:
Coloplast A/S |
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Apr 2021
|
|
Related companies:
Bavarian Nordic A/S |
|
|
| Poster Presentations to highlight the latest research on OBI-3424 (AKR1C3 small molecule pro-drug), OBI-998 (SSEA-4 ADC) and the glycosphingolipid cancer antigens, Globo H and SSEA-4. Read more ›› |
|
By: PR Newswire Association LLC. - 06 Apr 2021
|
|
Related companies:
OBI Pharma, Inc. |
Mimosa OBI AS |
OBI Medical ApS |
OBI Pharma, Inc. |
|
|
| Poster Presentations to highlight the latest research on OBI-3424 (AKR1C3 small molecule pro-drug), OBI-998 (SSEA-4 ADC) and the glycosphingolipid cancer antigens, Globo H and SSEA-4. Read more ›› |
|
By: PR Newswire Association LLC. - 06 Apr 2021
|
|
Related companies:
OBI Pharma, Inc. |
Mimosa OBI AS |
OBI Medical ApS |
OBI Pharma, Inc. |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 06 Apr 2021
|
|
Related companies:
IRRAS AB (publ) |
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Apr 2021
|
|
|
|
|
|
Biotechgate Global Database ›
